Public support for personalized and precision medicine (PM) is running ahead of the health care industry’s plans to develop and implement PM-based clinical strategies. At least that is the conventional thinking, supported by two recent studies. (See "Public Ahead of Providers in Support of Personalized Medicine," Lab & Pathology Insider, Oct. 26, 2016, for details…
Quest Diagnostics Unveils a Pair of Personalized Medicine Blockbusters
Public support for personalized and precision medicine (PM) is running ahead of the health care industry’s plans to develop and implement PM-based clinical strategies. At least that is the conventional thinking, supported by two recent studies. (See "Public Ahead of Providers in Support of Personalized Medicine," Lab & Pathology Insider, Oct. 26, 2016, for details […]